Information Library
Cost control/reduction - Phase IIIB/IV
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
QUINTILES INCREASES CAPACITY TO SUPPORT EUROPEAN CLINICAL TRIALS
September 24, 2009 - Quintiles Transnational Corp. today announced the opening of an expanded regional facility near Edinburgh, Scotland. Located within the Alba Campus, a research and development center near Edinburgh, the 115,000-square-foot building hosts more than 500 employees and has space for Quintiles Clinical Development Services, including Project Management, Regulatory Affairs and Data Management. -
Clinical Development Services
June 18, 2009
Find out how large pharmaceutical companies and emerging biotech move products past each development milestone. -
Early phase strategies
June 15, 2009
Web cast about Early Phase Strategies. -
Risk Assessment & Strategy
April 16, 2009
Quintiles benefit risk analysis can help you anticipate potential regulatory concerns and highlight the benefit side of your drug’s benefit risk profile. -
How to Navigate the New CDISC Standard
March 25, 2009
Quintiles – a CDISC Registered Solutions Provider – helps you get every detail right. -
Antibiotic Safety Assessment
March 25, 2009
A major pharmaceutical company presented Quintiles with a pressing challenge – to collect extensive amounts of Phase IV data in compressed time windows because the treatment conditions were subject to seasonal variants.
Page 1 of 1 (6 items)